Minori Rosales
Directeur Technique/Scientifique/R&D chez COMPASS THERAPEUTICS, INC.
Postes actifs de Minori Rosales
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| COMPASS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2023 | - |
Historique de carrière de Minori Rosales
Anciens postes connus de Minori Rosales
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2022 | 01/05/2023 |
| MACROGENICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2018 | 01/01/2022 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/10/2017 | 01/01/2018 |
Formation de Minori Rosales
| Yamaguchi University | Doctorate Degree |
| Kansai Medical University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Japon | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MACROGENICS, INC. | Health Technology |
| COMPASS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Minori Rosales
- Expérience
